Search Results - "Kjellman, A."

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) by Tandstad, T., Ståhl, O., Dahl, O., Haugnes, H.S., Håkansson, U., Karlsdottir, Å., Kjellman, A., Langberg, C.W., Laurell, A., Oldenburg, J., Solberg, A., Söderström, K., Stierner, U., Cavallin-Ståhl, E., Wahlqvist, R., Wall, N., Cohn-Cedermark, G.

“…The purpose of the protocol was to reduce the treatment burden in clinical stage I (CSI) seminoma by offering risk-adapted treatment. The protocol aimed to…”
Get full text

Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator‐mandated cohort postauthorization safety study in Denmark, Norway, and Sweden by Ehrenstein, Vera, Heide‐Jørgensen, Uffe, Schiødt, Morten, Akre, Olof, Herlofson, Bente Brokstad, Hansen, Svein, Larsson Wexell, Cecilia, Nørholt, Sven Erik, Tretli, Steinar, Kjellman, Anders, Glennane, Anthony, Lowe, Kimberly A., Sørensen, Henrik T.

“…BACKGROUND Osteonecrosis of the jaw (ONJ) is an adverse effect of antiresorptive treatment. This study estimated incidence proportions and incidence rates of…”
Get full text

Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients by Gerdtsson, Axel, Torisson, Gustav, Thor, Anna, Grenabo Bergdahl, Anna, Almås, Bjarte, Håkansson, Ulf, Törnblom, Magnus, Negaard, Helene F. S., Glimelius, Ingrid, Halvorsen, Dag, Karlsdóttir, Ása, Haugnes, Hege Sagstuen, Larsen, Signe Melsen, Holmberg, Göran, Wahlqvist, Rolf, Tandstad, Torgrim, Cohn‐Cedermark, Gabriella, Ståhl, Olof, Kjellman, Anders

“…Objective To validate Vergouwe's prediction model using the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) RETROP database and to define its…”
Get full text

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma by Karlsson Rosenblad, Andreas, Sundqvist, Pernilla, Harmenberg, Ulrika, Hellström, Mikael, Hofmann, Fabian, Kjellman, Anders, Kröger Dahlin, Britt-Inger, Lindblad, Per, Lindskog, Magnus, Lundstam, Sven, Ljungberg, Börje

“…To examine the association between surgical waiting times (SWTs) and all-cause mortality (ACM) in non-metastatic patients with RCC, in relation to tumour…”
Get more information

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening by Kjellman, A., Akre, O., Gustafsson, O., Høyer‐Hansen, G., Lilja, H., Norming, U., Piironen, T., Törnblom, M.

“…  Kjellman A, Akre O, Gustafsson O, Høyer‐Hansen G, Lilja H, Norming U, Piironen T, Törnblom M (Department of Clinical Science, Intervention, and Technology;…”
Get full text

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study by Lindskog, Magnus, Laurell, Anna, Kjellman, Anders, Melichar, Bohuslav, Rey, Pablo Maroto, Zieliński, Henryk, Villacampa, Felipe, Bigot, Pierre, Zoltan, Bajory, Parikh, Omi, Alba, David Vazquez, Jellvert, Åsa, Flaskó, Tibor, Gallardo, Enrique, Caparrós, Maria José Ribal, Purkalne, Gunta, Suenaert, Peter, Karlsson-Parra, Alex, Ljungberg, Börje

“…Intratumoral injection of ilixadencel, consisting of proinflammatory allogeneic dendritic cells, before nephrectomy, followed by sunitinib treatment after…”
Get full text

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events by Acquavella, John, Ehrenstein, Vera, Schiødt, Morten, Heide-Jørgensen, Uffe, Kjellman, Anders, Hansen, Svein, Larsson Wexell, Cecilia, Herlofson, Bente Brokstad, Noerholt, Sven Erik, Ma, Haijun, Öhrling, Katarina, Hernandez, Rohini K, Sørensen, Henrik Toft

“…Osteonecrosis of the jaw (ONJ) is a recognized complication of potent antiresorptive therapies, especially at the doses indicated to prevent skeletal…”
Get full text

Location and histology of retroperitoneal metastases in post-chemotherapy retroperitoneal lymph node dissection for non-seminoma germ cell tumour by Gerdtsson, A., Thor, A., Grenabo, A., Almås, B., Negaard, H.F.S., Glimelius, I., Halvorsen, D., Karlsdóttir, Á., Haugnes, H.S., Andreassen, K.E., Larsen, S.M., Holmberg, G., Wahlqvist, R., Tandstad, T., Cohn-Cedermark, G., Ståhl, O., Kjellman, A.

Get full text

The value of prostate-specific antigen density in long-term prostate cancer-mortality risk prediction by Yousef Yacoub, S., Lundgren, P., Kjellman, A., Gustafsson, O.

Get full text

A1195 - The value of prostate-specific antigen density in long-term prostate cancer-mortality risk prediction by Yousef Yacoub, S., Lundgren, P., Kjellman, A., Gustafsson, O.

Get full text

FROM DESCRIPTIVISM TO CONSTRUCTIVISM ‐ A CHALLENGE TO SYMBOLIC MODELING. II by Kjellman, A.

“…Classical modeling is not isomorphic, on the contrary the “objects of reality” or the like is the source of a homomorphic mapping performed to produce the…”
Get full text

P216 Surgical results of robot-assisted post chemotherapy RPLND surgery by Kjellman, A., Bergkvist, M., Lundgren, P-O., Thor, A.

Get full text

Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality Reply by Lundgren, P-O, Kjellman, A, Norming, U, Gustafsson, O

Get full text

Reply to the letter by Ferraro and Biganzoli by Lundgren, Per‐Olof, Kjellman, Anders, Norming, Ulf, Gustafsson, Ove

Get full text

The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm by Thor, A., Grenabo Bergdahl, A., Almas, B., Halvorsen, D., Cohn Cedermark, G., Neegaard, H., Karlsdottir, A., Sagstuen Haugnes, H., Stahl, O., Gerdtsson, A., Melsen Larsen, S., Tandstad, T., Kjellman, A.

Get full text

A0755 - The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm by Thor, A., Grenabo Bergdahl, A., Almas, B., Halvorsen, D., Cohn Cedermark, G., Neegaard, H., Karlsdottir, A., Sagstuen Haugnes, H., Stahl, O., Gerdtsson, A., Melsen Larsen, S., Tandstad, T., Kjellman, A.

Get full text

Association between one‐time prostate‐specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30‐year prospective cohort study by Lundgren, Per‐Olof, Kjellman, Anders, Norming, Ulf, Gustafsson, Ove

“…Objectives To explore if there is a long‐term association between baseline prostate‐specific antigen (PSA), including free/total PSA ratio and long‐term…”
Get full text

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer by Lundgren, Per‐Olof, Tribukait, Bernhard, Kjellman, Anders, Norming, Ulf, Jagarlmudi, Kiran, Gustafsson, Ove

“…Background Thymidine kinase 1 (TK1) recycles DNA before cell division. We do not know if baseline blood concentrations of TK1 predict death in prostate cancer…”
Get full text

Long-Term Outcome of a Single Intervention Population Based Prostate Cancer Screening Study by Lundgren, Per-Olof, Kjellman, Anders, Norming, Ulf, Gustafsson, Ove

“…We evaluated the long-term effect of screening for prostate cancer. In 1988 we randomly selected 2,400 men from a background population of 27,464 men. The…”
Get full text

Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer by Tribukait, Bernhard, Lundgren, Per-Olof, Kjellman, Anders, Norming, Ulf, Nyman, Claes R, Jagarlmundi, Kiran, Gustafsson, Ove

“…Thymidine kinase 1 (TK1) is an intracellular enzyme involved in DNA-precursor synthesis. Increased serum TK1 levels are used as a biomarker in various…”
Get full text